These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21153897)

  • 21. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Boivin P
    Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycythaemia vera, ruxolitinib, and hydroxyurea: where do we go now?
    Spivak JL
    Lancet Haematol; 2020 Mar; 7(3):e184-e185. PubMed ID: 31982040
    [No Abstract]   [Full Text] [Related]  

  • 23. Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment.
    Kikuchi K; Arita K; Tateishi Y; Onozawa M; Akiyama M; Shimizu H
    Acta Derm Venereol; 2011 May; 91(3):373-4. PubMed ID: 21336478
    [No Abstract]   [Full Text] [Related]  

  • 24. Aggressive cutaneous squamous cell carcinoma in a hydroxyurea- and ruxolitinib-pretreated patient with polycythaemia vera.
    Gambichler T; Stockfleth E; Susok L
    J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():63-65. PubMed ID: 34855240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemic transformation in polycythemia Vera. MPD(UK) Study Group.
    Pearson TC; Green AR; Reilly JT; Harrisoni G
    Blood; 1998 Sep; 92(5):1837-8. PubMed ID: 9716616
    [No Abstract]   [Full Text] [Related]  

  • 26. Cutaneous effects after prolongaded use of hydroxyurea in Polycythemia Vera.
    França ER; Teixeira MA; Matias Kde F; Antunes DE; Braz Rde A; Silva CE
    An Bras Dermatol; 2011; 86(4):751-4. PubMed ID: 21987143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea.
    Hamada T; Kawata M; Maeda Y; Yoshino T; Miyake T; Morizane S; Hirai Y; Iwatsuki K
    J Dermatol; 2018 Apr; 45(4):e82-e83. PubMed ID: 29139148
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxyurea and sickle cell crisis.
    Silver RT
    N Engl J Med; 1995 Oct; 333(15):1008-9. PubMed ID: 7666903
    [No Abstract]   [Full Text] [Related]  

  • 29. [Leg ulcer in a patient treated with hydroxyurea for polycythemia vera].
    Hanchi I; Zeglaoui F; Ezzine N; Daoud L; Karoui M; Fazaa B; Ridha Kamoun M
    Presse Med; 2006; 35(7-8):1174-6. PubMed ID: 16840894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
    Gisslinger H; Klade C; Georgiev P; Krochmalczyk D; Gercheva-Kyuchukova L; Egyed M; Rossiev V; Dulicek P; Illes A; Pylypenko H; Sivcheva L; Mayer J; Yablokova V; Krejcy K; Grohmann-Izay B; Hasselbalch HC; Kralovics R; Kiladjian JJ;
    Lancet Haematol; 2020 Mar; 7(3):e196-e208. PubMed ID: 32014125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxyurea in the treatment of polycythemia vera: a prospective study of 100 patients over a 20-year period.
    West WO
    South Med J; 1987 Mar; 80(3):323-7. PubMed ID: 3824016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of polycythemia vera with hydroxyurea.
    Sharon R; Tatarsky I; Ben-Arieh Y
    Cancer; 1986 Feb; 57(4):718-20. PubMed ID: 3943010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent pyrexia, cough and dyspnoea with hydroxyurea.
    Grace RF; Shenfield GM; Grant J; Ravich R
    Aust N Z J Med; 1998 Jun; 28(3):347. PubMed ID: 9673751
    [No Abstract]   [Full Text] [Related]  

  • 34. The optimal management of polycythaemia vera.
    McMullin MF; Bareford D; Craig J; Green AR; Harrison C; Oscier DG; Reilly JT;
    Br J Haematol; 2003 Feb; 120(3):543-4; author reply 544-5. PubMed ID: 12580978
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hydroxyurea in the treatment of erythremia].
    Demidova AV
    Ter Arkh; 1993; 65(9):82-4. PubMed ID: 8303607
    [No Abstract]   [Full Text] [Related]  

  • 36. Hydroxyurea therapy increases plasma erythropoietin in patients with essential thrombocythaemia or polycythaemia vera.
    Johansson P; Andréasson B
    Clin Lab Haematol; 2006 Aug; 28(4):233-6. PubMed ID: 16898960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatomyositis-like eruption after long-term hydroxyurea therapy for polycythemia vera.
    Oskay T; Kutluay L; Ozyilkan O
    Eur J Dermatol; 2002; 12(6):586-8. PubMed ID: 12459535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester.
    Pata O; Tok CE; Yazici G; Pata C; Oz AU; Aban M; Dilek S
    Am J Perinatol; 2004 Apr; 21(3):135-7. PubMed ID: 15085495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
    Ferrari A; Carobbio A; Masciulli A; Ghirardi A; Finazzi G; De Stefano V; Vannucchi AM; Barbui T
    Haematologica; 2019 Dec; 104(12):2391-2399. PubMed ID: 31123026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydroxyurea-induced cutaneous ulceration in older patients.
    Yeh H; Lichtman SM
    J Am Geriatr Soc; 2000 Feb; 48(2):232. PubMed ID: 10682958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.